iEvac-Z, an Inactivated Ebola Vaccine — Phase 1 Study in Japan

T Tokiko Watanabe (University of Osaka, Osaka, Japan) M Michiko Koga (University of Tokyo, Tokyo) M Masanori Nojima (University of Tokyo, Tokyo) M Minako Kono (University of Tokyo, Tokyo) Y Yuriko Tomita (University of Tokyo, Tokyo) T Tadashi Maemura I Itsuki Anzai (University of Osaka, Osaka, Japan) Y Yuri Furusawa (University of Tokyo, Tokyo) C Calvin Duong (University of Tokyo, Tokyo) Y Yoichiro Kino (Kino Consulting, Kumamoto, Japan) P Peter J. Halfmann F Fumitaka Nagamura (University of Tokyo, Tokyo) H Hiroshi Yotsuyanagi (University of Tokyo, Tokyo) Y Yoshihiro Kawaoka

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 29, 2026
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (14)

T

Tokiko Watanabe

University of Osaka, Osaka, Japan

M

Michiko Koga

University of Tokyo, Tokyo

M

Masanori Nojima

University of Tokyo, Tokyo

M

Minako Kono

University of Tokyo, Tokyo

Y

Yuriko Tomita

University of Tokyo, Tokyo

T

Tadashi Maemura

I

Itsuki Anzai

University of Osaka, Osaka, Japan

Y

Yuri Furusawa

University of Tokyo, Tokyo

C

Calvin Duong

University of Tokyo, Tokyo

Y

Yoichiro Kino

Kino Consulting, Kumamoto, Japan

P

Peter J. Halfmann

F

Fumitaka Nagamura

University of Tokyo, Tokyo

H

Hiroshi Yotsuyanagi

University of Tokyo, Tokyo

Y

Yoshihiro Kawaoka